Supplementary Table 1 from First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies

Authors :: Michelle Scurr
George Demetri
Stan B. Kaye
S. Gail Eckhardt
Andrew Stephens
Katie Brock
Richard Gedrich
Ramesh Boinpally
Srinivasu Poondru
Jon Chick
Martin O. Leach
Nandita M. Desouza
James Spicer
Rohit Lal
Jennifer L. Spratlin
Stephen J. Gwyther
Natalie J. Serkova
Suzanne George
D. Ross Camidge
Hendrik-Tobias Arkenau
Timothy A. Yap
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 56K, FDG-PET Responses

Tools